Figure 3.
Utility of chondrocyte products as diagnostic and prognostic markers. Cartilage oligomeric matrix protein (COMP), collagen type I (TXI), C1M, C2M, C3M, YKL-40, MIA, C2C/CPII ratio, and type II collagen (CTX-II) were reported to have diagnostic prognostic significance for disease activity, treatment response, radiographic progression, and angiogenesis.